Current Edition


Daiichi acquires another ADC drug through Glycotope licensing deal

Daiichi Sankyo is bringing a seventh antibody-drug conjugate, or ADC, into its pipeline through a licensing agreement with German biotech Glycotope. Specific financials weren’t disclosed, …

Continue Reading →

PharmaKrysto announces licensing agreement with Rutgers University for new treatment for people with cystinuria

PharmaKrysto Ltd, a biopharmaceutical company based in Scotland, UK, announces today that it has completed an exclusive global licensing deal with Rutgers University, New Jersey, …

Continue Reading →